ADC Therapeutics Cuts Debt, Extends Runway Ahead of Key Drug Data, RBC Says
ADC Therapeutics (ADCT) cut debt and extended its cash runway, reducing pressure on its balance shee
Keep reading this article with Yahoo Finance Plus Silver
Silver
- Premium news Full access to Financial Times and MT Newswires articles
- Stock picks Expert picks from Motley Fool, Zacks, and Moby
- Research reports Expert analysis from Morningstar and Argus
